Navigation Links
Make Lashes Longer, Thicker, and Darker with Latisse™
Date:2/12/2009

Mascara may not be the only thing that can be using to enhance eyelashes. Latisse™, a revolutionary new treatment for eyelash growth has arrived. Latisse™ was developed through years of research by Allergan, a pharmaceutical leader with over 60 years of expertise in prescription eye care products.

Beverly Hills, CA (PRWEB) February 12, 2009 -- Latisse™ (bimatoprost-ophthalmic-solution) 0.03%, approved by the U.S. Food and Drug Administration (FDA) in 2008, is a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. Prior to its FDA approval, Allergan conducted a 16 week clinical trial with approximately 280 volunteers to assess the safety and efficacy of Latisse™. The results exceeded expectations. Participants experienced lashes 25 percent longer, 106 percent thicker and 18 percent darker.

The story of Latisse unexpectedly began in ophthalmology offices and the treatment of glaucoma patients. A new class of medications known as prostamides had been developed to lower intraocular eye pressure and doctors noticed a surprising side effect: the prostamides also grew hair. Allergan produced Lumigan (the trade name for ophthalmic formulated bimatoprost solution) quickly became the most popular prostamide. Products such as Revitalash and Age Intervention were the first to hit the market. However, because of purported patent infringements, the makers of Age Intervention were forced to cease production. Their replacement product Marini Lash does not contain bimatoprost and as result is considered by many to be less effective than Latisse™.

"After using the product, my eyelashes really stand out. I get compliments all the time and it feels great! Everyone wants to know my secret. People even ask if I am wearing false eyelashes. I feel more confident knowing this product, unlike other lash growth products on the market, is FDA-approved. I will absolutely tell all of my friends (and anyone who asks) about this new lash growth product," states Lisa, an Allergan clinical study test subject.    

Available only by prescription, Epione is among the first medical offices to carry Latisse™. According to Epione's Medical Director, Dr. Simon Ourian, users can expect to grow longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks. To maintain this effect, continued treatment with Latisse™ is required. If use of Latisse™ is discontinued, eyelashes will gradually return to their pre-treatment state over a period of weeks to months (the average eyelash follicle cycle).

"Clinical studies have shown that Latisse™ works well. Virtually everyone who has used it has seen great results. Until now people looking for longer eyelash had to apply cosmetics such as mascara or glue false eyelashes onto their eyelids. Now with Latisse Epione is proud to offer our patients a new option for making their eyelashes longer," says Dr. Ourian.

Dr. Ourian's Epione Medical Corporation, located in Beverly Hills Golden Triangle, is among the most comprehensive and state-of-the-art laser and aesthetic surgery centers. Dr. Ourian has been a pioneer for laser technology and non-invasive aesthetic procedures such as BOTOX®, Restylane, Radiesse and Sculptra. These treatments are used for correction or reversal of a variety of conditions such as acne, acne scars, skin discoloration, wrinkles, stretch marks, varicose veins, unwanted hair, and tattoos, cellulite, and tens of others. For further information please contact 310-271-6506 or visit www.epione.com

###

Read the full story at http://www.prweb.com/releases/latisselongerlashes/allerganeyes/prweb1972044.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Flaxseed May Relieve Hot Flashes
2. From Hot Flashes to Breast Cancer: ZRT Labs Hormone Testing Catches On As Women Consider Safer, More Natural Options.
3. News Flash on Hot Flashes: Soy Can Turn Down the Heat
4. Radius Announces Launch of RAD1901 Clinical Program for the Treatment of Hot Flashes
5. Hot Flashes Not Always to Blame for Sleep Problems in Menopausal Women, Reports the Harvard Womens Health Watch
6. Cool new treatment for hot flashes in breast cancer survivors
7. Cool New Treatment for Hot Flashes in Breast Cancer Survivors
8. Hot Flashes Reduced by Neck Injection
9. Hot flashes underreported and linked to forgetfulness
10. Menopause: Hot Flashes Can Be Reduced 90% without Hormones
11. Hot Flashes, Night Sweats a Good Sign for Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Make Lashes Longer, Thicker, and Darker with Latisse™
(Date:5/26/2016)... ... 26, 2016 , ... Dr. James Maisel will present on ... Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public Library. The ... Group of New York , is a Board Certified ophthalmologist who completed his ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of Life Science Logistics ... organization has earned its ISO 13485 certification, indicating the company’s quality control system ... and policies associated with ISO quality standard 13485. , BSI Group America, ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... multitude of activities from daily practices, arts & crafts, discussions, and games all ... East-D’Anna and Christy Evans have combined backgrounds in kids’ yoga, collegiate sport yoga ...
(Date:5/26/2016)... ... 26, 2016 , ... Power Systems, a leading developer and ... Certification Course in Stoughton, Massachusetts. The course was led by Power Systems’ Education ... hour interactive course to qualify participants as certified PowerWave trainers. , PowerWave ...
(Date:5/26/2016)... ... ... A health conscious snack that doesn't sacrifice taste? It's possible! In one ... buzz in the protein product community by offering an alternative to the traditional bar ... with 11 grams of protein and made from a healthy blend of high quality ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... NEW YORK , May 25, 2016 ... Device Market Size, Share, Development, Growth and Demand Forecast ... Insulin Syringe, Insulin Pump and Others)" published by P&S ... valued at $9,998.3 million in 2015, and it is ... 2016-2022. Based on type, the insulin pump segment is ...
Breaking Medicine Technology: